According to @business, Pfizer (PFE) has increased its offer for obesity drug startup Metsera in an escalating bidding contest with Novo Nordisk (NVO), citing unnamed sources. Source: Bloomberg @business, Nov 8, 2025. In multi-bidder takeovers, target premiums and deal success probabilities typically rise, which can re-rate peer valuations across the GLP-1 obesity drug cohort during price discovery. Source: Betton, Eckbo, and Thorburn, Corporate Takeovers, Handbook of Corporate Finance, 2008. Bidder shares often show short-term negative abnormal returns when raising offers due to expected dilution and integration risk, particularly in large acquisitions. Source: Moeller, Schlingemann, and Stulz, Journal of Finance, 2005. The report does not mention any direct cryptocurrency market impact; no BTC or ETH implications are stated in the source. Source: Bloomberg @business, Nov 8, 2025.

According to @business, Alimentation Couche-Tard abandoned its $44.4 billion bid for Seven & i nearly three months ago (source: Bloomberg @business). According to @business, Seven & i shares remain 24% below the proposed bid price with few signs of reversing, indicating a sustained valuation gap relative to the offer level that traders should note for event-driven setups (source: Bloomberg @business). According to @business, with the bid withdrawn, the discount reflects post-deal repricing rather than an active merger-arbitrage spread, framing expectations for liquidity and positioning in Japan retail equities (source: Bloomberg @business). According to @business, the post provides no direct linkage to digital assets, implying no immediate crypto-market catalyst based on the disclosed information (source: Bloomberg @business).